Latest News
Featured News
Scancell initiates new arm (Cohort 4) in SCOPE Phase 2 study to evaluate intradermal administration and an accelerated dosing regimen for iSCIB1+
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Select the category
Change of Date for Final Results and Investor Presentation
Notice of Final Results and Investor Presentation
Scancell announces positive data from the first stage in its Phase 2 SCOPE trial with SCIB1 cancer vaccine delivered by needle free injection for advanced melanoma
Scancell to present three posters at the Seventh International Cancer Immunotherapy Conference
Scancell Appoints Dr Mandeep Sehmi as Head of Business Development
Scancell Appoints Sath Nirmalananthan as Chief Financial Officer
No results found.
Regulatory News Archive
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.